Home・Elenco Azioni・Collegium Pharmaceutical Inc

C
Collegium Pharmaceutical Inc

Chiusa

SettoreSettore sanitario

27.33 0.48

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

26.69

Massimo

27.95

Metriche Chiave
By Trading Economics
Entrata	-30M -15M
Vendite	6.4M 200M
P/E Media del settore	22.228 57.371
EPS	1.57
Margine di Profitto	-7.53
Dipendenti	423
EBITDA	-20M 71M

Raccomandazioni
By TipRanks
Raccomandazioni	Fortemente da comprare
Previsioni per 12 mesi	+81.67% upside

Dividendi
By Acuity
Utili prossimi	5 nov 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-279M 875M
Apertura precedente	26.85
Chiusura precedente	27.33

Notizie sul Sentiment di mercato

By Acuity

32%

68%

104 / 340 Classifica in Healthcare

Collegium Pharmaceutical Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

24 ago 2026, 22:02 UTC

Collegium Pharmaceutical shares advanced in after-market trading, despite being below their 20-day moving average and weaker compared to a month ago.

21 ago 2026, 20:13 UTC

Collegium Pharmaceutical Inc. shares are trading roughly flat after-market, with no specific news identified. The stock remains below its 20-day moving average.

20 ago 2026, 20:01 UTC

Collegium Pharmaceutical shares are lower amid broader market pressures, reflecting negative sentiment following Walmart's disappointing earnings report.

19 ago 2026, 19:56 UTC

Collegium Pharmaceutical Inc. shares are higher since Tuesday's close, reaching a session high earlier before pulling back within routine trading patterns.

18 ago 2026, 19:56 UTC

Collegium Pharmaceutical Inc is trading higher today, though no specific news was identified to explain the movement. The stock remains below its 20-day moving average.

17 ago 2026, 19:36 UTC

Collegium Pharmaceutical Inc shares are higher during Monday's session, reaching a peak gain earlier today before retracing. No specific news was identified for the movement.

14 ago 2026, 19:21 UTC

Collegium Pharmaceutical Inc shares are lower today, reflecting a broader downturn in the Pharmaceuticals sector. The stock remains below its 20-day moving average.

13 ago 2026, 22:51 UTC

Collegium Pharmaceutical Inc shares rose in after-market trading, reflecting broader market gains amid unchanged producer prices and easing inflation expectations.

12 ago 2026, 19:51 UTC

Collegium Pharmaceutical Inc's shares are lower today, continuing a trend of recent weakness amid unusually high market volume. No specific news was identified.

11 ago 2026, 22:01 UTC

Collegium Pharmaceutical Inc shares are higher in after-market trading, reversing earlier session dips and showing strength after three consecutive lower closes.

10 ago 2026, 21:01 UTC

Collegium Pharmaceutical Inc shares are lower in after-market hours, continuing a trend since Monday's close, and are significantly below their 20-day moving average.

7 ago 2026, 21:01 UTC

Collegium Pharmaceutical Inc shares are trading higher in after-market hours. No specific news was identified to explain the movement.

6 ago 2026, 23:11 UTC

Collegium Pharmaceutical Inc shares are higher in after-market hours, recovering from an initial dip but remain below their 20-day moving average.

4 ago 2026, 19:26 UTC

Collegium Pharmaceutical Inc shares are lower today, trading near the lower end of their one-month range, with no specific news driving the decline.

3 ago 2026, 19:46 UTC

Collegium Pharmaceutical Inc is trading lower today, continuing a three-session decline. The stock peaked early but has since pulled back.

31 lug 2026, 20:06 UTC

News

Collegium Pharmaceutical is under scrutiny due to concerns over its financial performance, contributing to a decline in shares during Friday's session.

30 lug 2026, 20:09 UTC

Collegium Pharmaceutical Inc shares are lower in Thursday's session, with no specific news to explain the decline amid broader market volatility.

29 lug 2026, 22:01 UTC

Collegium Pharmaceutical Inc is trading higher in after-market hours, continuing a positive trend with gains over four consecutive sessions amid cautious investor sentiment.

28 lug 2026, 22:01 UTC

Collegium Pharmaceutical Inc shares are lower in after-market hours, continuing a decline from Tuesday's close amid broader market pressures, particularly in Asia.

27 lug 2026, 19:07 UTC

News

Collegium Pharmaceutical reported first-quarter revenues of $193.5 million, surpassing expectations, while shares are trading higher amid broader strength in the pharmaceutical sector.

24 lug 2026, 19:46 UTC

Collegium Pharmaceutical Inc shares are lower during Friday's session, with no specific news identified to explain the decline. The stock remains near its one-month trading range.

22 lug 2026, 20:01 UTC

Collegium Pharmaceutical Inc shares are lower today, continuing a downward trend seen since Tuesday's close, with no specific news identified for the decline.

21 lug 2026, 20:01 UTC

Collegium Pharmaceutical Inc is trading higher amid a broader market rally, with the Pharmaceuticals sector also gaining momentum. No specific news was identified.

20 lug 2026, 19:41 UTC

News

Collegium Pharmaceutical plans to move its headquarters to Boston in 2027. Shares are lower amid significant declines in the Pharmaceuticals sub-sector.

Confronto tra pari

Modifica del prezzo

Collegium Pharmaceutical Inc Previsione

Obiettivo di Prezzo

By TipRanks

81.67% in crescita

Previsioni per 12 mesi

Media 49.25 USD 81.67%

Alto 60 USD

Basso 43 USD

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Collegium Pharmaceutical Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

4 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 4 che hanno fornito valutazioni azionarie a Collegium Pharmaceutical Inc - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

104 / 340 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Collegium Pharmaceutical Inc

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.